We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
CareGREEN is an innovation company that has created a unique air pollution capture and storage technology with the aim to reduce harmful pollution in the atmosphere. Their latest product is the Environmental Air Purification Intervention & Control System (EAPICS). The technology has been accredited as a significant solution in reducing COx worldwide. A World Health Organisation (2016) report established that more than 80% of people living in urban areas face the greatest environmental risk to their health today due to air pollution. CareGREEN believes its specialised filtration systems will contribute to a considerable fall in health issues linked to poor air quality. It is also diversifying its reach in other renewable energy sectors such as solar and wind. The company will utilise the investment to scale its business.
days to go: Expired investment: Withheld
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go: Expired investment: Withheld
Targeting heavy-duty diesel engines the Cibus21 retrofit technology system claims it is fuel-saving and reduces harmful exhaust emissions through the principle of Enhanced Combustion. With patents pending the company claims the enhanced combustion process introduces small amounts of LPG directly into the diesel engines' air intake to fundamentally change the chemistry of the combustion process. The company states that the current experienced efficiency gains are 15-20% reduced in diesel use and CO2 emissions.
days to go: Expired investment: £116,000
Cipher Surgical have developed a new product that is designed to remove contaminants from the laparoscope’s lens during keyhole surgery, thus removing the need to constantly take the laparascope out of the patient for cleaning. This is done by manipulating CO2 and saline across the lens and therefore removing blood, peritoneal fluid, particulate matter and condensation/fogging from the lens.
days to go: Expired investment: £175,000
City Fiction is a newly established media company. It publishes Tony Drury's City thrillers and works with others to produce films based on individual titles. Books and scripts are in place. Stage 2 is to generate sales.
days to go: Expired investment: £2,500
Carbon Negative Permeable Pavement Systems (CNPPS) offers Carbon Negative solution for hard surfaces like pavements and road networks. The company uses secondary aggregates, waste products and carbon-negative materials in its pavement systems which absorb more carbon in the manufacturing process than the carbon emitted per square meter by traditional carbon-intensive road construction methods. CNPPS's products are also permeable and can reduce flooding caused by rainwater run-off, thereby improving road safety. The company argues that its products are an estimated 5-8% less expensive than the currently used processes, having the potential to lessen the infrastructure budgets of the UK government. CNPPS requires initial funding to carry out a trial of its system by the Highways of England.  The company will use the investment funds to trial, accredit, CE mark and market CNPPS, and generate buyer interest in its products. 
days to go: Expired investment: Withheld
CommSoft have developed a language solution called Language Assistant. Language Assistant is a multi-language conversation automation technology and has been hailed as a national first for its deployment in police custody. 
days to go: Expired investment: £21,732
Co-Space is a forward-thinking flexible office operator with a focus on affluent towns and cities outside Central London. Established in 2018, Co-Space has thrived even during the pandemic, boasting two successful sites in Reading (95% occupied) and Stevenage (93% occupied). Our approach involves transforming underutilized spaces into highly sought-after flexible offices, incorporating exceptional interior design and dedicated service. With a revenue run rate of £1.5 million and over 90% of it being contracted and recurring, Co-Space is a promising contender, bridging the gap between exceptional London design and regional competition.
days to go: Expired investment: £50,000
Crowd for Angels (UK) Limited is an FCA regulated crowdfunding platform that provides investors and companies with an opportunity to invest and raise funds. The company was launched in 2014, since then, it has funded dozens of bond pitches and shares. The company has recently specialised into the crowdfunding of tokenised assets. The company has tokenised assets or securities that differentiate from a normal crowdfunding event. With the proceeds, the company will work on its working capital, expand its registered user base, and further its funds and investments.
days to go: Expired investment: Withheld
Cyance is an award-winning marketing technology pioneer. Nexus is a software platform designed by the company to track the buying behaviour through billions of computers belonging to millions of businesses across the globe. This platform can track the consumed content and identifies customer interests and needs. The company's customers typically generate x3 more leads and x4 more sales. With the proceeds, Cyance will increase its marketing sales and improve product development to fund the general working capital.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph